Fixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipation.

Fixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipation.

Item
http://www.wikidata.org/entity/Q34131602
Intractable restless legs syndrome: role of prolonged-release oxycodone-naloxoneTherapeutic effect of activated carbon-induced constipation mice with Lactobacillus fermentum Suo on treatment.Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain.A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.Is oxycodone/naloxone effective and safe in managing chronic pain of a fragile elderly patient with multiple skin ulcers of the lower limbs? A case report.Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice.High doses of oxycodone-naloxone combination may provide poor analgesia.Validated in vitro/in vivo correlation of prolonged-release oxycodone/naloxone with differing dissolution rates in relation to gastrointestinal transit times.Nanoconjugated NAP as a Potent and Periphery Selective Mu Opioid Receptor Modulator To Treat Opioid-Induced Constipation.Patient preference with respect to QoL and reduction in opioid-induced constipation (OIC) after treatment with prolonged-release (PR) oxycodone/naloxone compared with previous analgesic therapy [PREFER study].[Pharmacological treatment of constipation].Efficacy and gastrointestinal tolerability of oral oxycodone/naloxone combination for chronic pain in outpatients with cancer: an observational study.Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.
P2860

Fixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipation.

Item
http://www.wikidata.org/entity/Q34131602
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Fixed combination of oxycodone ...... t opioid-induced constipation.
@ast
Fixed combination of oxycodone ...... t opioid-induced constipation.
@en
Fixed combination of oxycodone ...... t opioid-induced constipation.
@nl
type
label
Fixed combination of oxycodone ...... t opioid-induced constipation.
@ast
Fixed combination of oxycodone ...... t opioid-induced constipation.
@en
Fixed combination of oxycodone ...... t opioid-induced constipation.
@nl
prefLabel
Fixed combination of oxycodone ...... t opioid-induced constipation.
@ast
Fixed combination of oxycodone ...... t opioid-induced constipation.
@en
Fixed combination of oxycodone ...... t opioid-induced constipation.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921
P356
P1433
P1476
Fixed combination of oxycodone ...... t opioid-induced constipation.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921